Generating destination analysis
Compass Direction
Earnings IntelligenceAI-Powered
Compass Score
Key Numbers
Market Cap
$140B
P/E
35
Revenue Growth
+10.0%
Gross Margin
N/A
ROE
N/A
About Stryker Corporation
Listed on the NYSE, Stryker Corporation operates as a large-cap player in the healthcare sector, participating in the biotech and genomics opportunity as part of a broader strategy. Medical technology leader in orthopedics, surgical equipment, and neurotechnology. Valued at 35x trailing earnings with a $140B market capitalization, the business is characterized by measured expansion, reporting +10% revenue change year-over-year.
Expert Coverage
Unlock Full SYK Analysis
Expert analysis and coverage for Stryker Corporation
Or unlock everything now with Compass, $9/moPrice & Technical Analysis
Price vs 200DMA
DMA Convergence
50 DMA
200 DMA
More in Biotech & Genomics
Beam Therapeutics
Base editing platform with differentiated gene-editing pipeline.
DexCom Inc.
Continuous glucose monitoring leader expanding beyond diabetes management.
Alnylam Pharmaceuticals
RNA interference therapeutics leader with approved treatments for rare diseases.
Recursion Pharmaceuticals
AI-driven drug discovery platform using machine learning to decode biology at scale.